Design Therapeutics Inc. (DSGN)
NASDAQ: DSGN
· Real-Time Price · USD
5.35
0.19 (3.68%)
At close: Aug 15, 2025, 3:59 PM
5.33
-0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT
Design Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 19.7M | 13.67M | 22.56M | 30.33M | 45.7M | 29.4M | 21.2M | 27.94M | 27.2M | 28.81M | 26.5M | 42.52M | 119.65M | 287.31M | 298.57M | 357.66M | 370.84M | 400.69M |
Short-Term Investments | 196.57M | 216.01M | 222.91M | 223.75M | 215.32M | 241.29M | 260.6M | 263M | 275.89M | 286.58M | 303.89M | 301.72M | 239.72M | 83.91M | 85.5M | 36.06M | 32M | 10.65M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 239.72M | n/a | 85.5M | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 427K | 427K | 427K | 429K | 427K | 430K | 437K | 444K | 452K | 459K | 466K | -239.25M | n/a | -85.5M | n/a | n/a | n/a |
Receivables | 1.35M | 1.41M | 1.26M | 1.18M | 1.4M | 1.68M | 1.43M | 1.21M | 994K | 974K | 1.11M | 746K | 691K | 100K | 110K | 47K | 76K | 27K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -994K | -974K | -1.11M | n/a | 1.42M | 2.44M | -110K | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.96M | 3.55M | n/a | n/a | 236K | 112K | n/a | n/a | n/a | n/a |
Total Current Assets | 219.79M | 233.64M | 248.04M | 257.24M | 264.84M | 273.89M | 284.58M | 294.54M | 306.05M | 318.94M | 335.12M | 348.49M | 361.72M | 373.87M | 385.44M | 395.29M | 404.88M | 411.75M |
Property-Plant & Equipment | 3.09M | 3.4M | 3.63M | 3.96M | 4.31M | 4.48M | 4.63M | 4.89M | 5.14M | 5.35M | 5.56M | 5.62M | 5.74M | 4.93M | 5.12M | 5.06M | 271K | 100K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 3.09M | 3.83M | 4.05M | 4.39M | 4.74M | 4.91M | 5.06M | 5.33M | 5.58M | 5.8M | 6.02M | 6.08M | 6.21M | 4.93M | 5.12M | 5.06M | 271K | 100K |
Total Assets | 222.89M | 237.47M | 252.09M | 261.63M | 269.58M | 278.79M | 289.64M | 299.87M | 311.63M | 324.74M | 341.14M | 354.57M | 367.93M | 378.8M | 390.56M | 400.35M | 405.15M | 411.85M |
Account Payables | 1.01M | 3.18M | 2.19M | 1.47M | 1.3M | 1.37M | 1.94M | 2.21M | 1.92M | 2.74M | 3.02M | 2.62M | 2.07M | 1.9M | 1.62M | 2.22M | 1.58M | 2.03M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -697K | -677K | n/a | n/a | n/a | n/a | n/a | -2.11M | n/a | n/a | n/a |
Short-Term Debt | 844K | 821K | 800K | 778K | 757K | 736K | 716K | 697K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 4.38M | 1.07M | 2.78M | 2.21M | 1.19M | 2.18M | 2.22M | n/a | 7.12M | 3.85M | 3.57M | 4.47M | 2.8M | 1.63M | 1.02M | 1.4M | 879K | 1.26M |
Total Current Liabilities | 8.75M | 8.24M | 8.46M | 7.43M | 6.39M | 7.09M | 9.62M | 12.39M | 12.13M | 9.05M | 10.78M | 10.41M | 7.39M | 5.48M | 5.28M | 5.5M | 3.4M | 3.71M |
Long-Term Debt | 1.1M | n/a | n/a | n/a | n/a | n/a | 2.33M | n/a | 2.7M | 2.88M | 3.05M | 3.22M | 3.38M | 3.01M | 3.14M | 3.27M | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | -2.33M | n/a | -2.7M | -2.88M | -3.05M | -3.22M | -3.38M | -3.01M | -3.14M | -3.26M | 140K | 142K |
Total Long-Term Liabilities | 1.1M | 1.32M | 1.53M | 1.74M | 1.95M | 2.14M | 2.33M | 2.52M | 2.7M | 2.88M | 3.05M | 3.22M | 3.38M | 3.01M | 3.14M | 3.28M | 140K | 142K |
Total Liabilities | 9.85M | 9.56M | 10M | 9.18M | 8.34M | 9.24M | 11.96M | 14.91M | 14.84M | 11.93M | 13.83M | 13.63M | 10.77M | 8.49M | 8.43M | 8.79M | 3.54M | 3.85M |
Total Debt | 1.1M | 2.14M | 2.33M | 2.52M | 2.7M | 2.88M | 3.05M | 3.22M | 3.38M | 2.88M | 3.69M | 3.84M | 3.98M | 3.52M | 3.63M | 3.75M | n/a | n/a |
Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K |
Retained Earnings | -264.01M | -244.93M | -227.21M | -213.56M | -200.52M | -188.73M | -177.63M | -165.78M | -150M | -130.06M | -110.76M | -93.42M | -75.72M | -60.72M | -47.46M | -36.39M | -25.07M | -17.44M |
Comprehensive Income | 305K | 450K | 475K | 914K | -217K | -167K | 62K | -1.28M | -2M | -1.98M | -3.36M | -3.86M | -2.31M | -1.32M | -244K | -4K | -12K | 2K |
Shareholders Equity | 213.04M | 227.92M | 242.1M | 252.45M | 261.24M | 269.56M | 277.69M | 284.96M | 296.8M | 312.82M | 327.31M | 340.94M | 357.16M | 370.31M | 382.13M | 391.56M | 401.6M | 408.01M |
Total Investments | 196.57M | 216.01M | 222.91M | 223.75M | 215.32M | 241.29M | 260.6M | 263M | 275.89M | 286.58M | 303.89M | 301.72M | 479.45M | 83.91M | 85.5M | 36.06M | 32M | 10.65M |